nadp has been researched along with Thyroid Cancer, Anaplastic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cheng, Q; Ma, L | 1 |
1 other study(ies) available for nadp and Thyroid Cancer, Anaplastic
Article | Year |
---|---|
Inhibiting 6-phosphogluconate dehydrogenase reverses doxorubicin resistance in anaplastic thyroid cancer via inhibiting NADPH-dependent metabolic reprogramming.
Topics: Cell Line, Tumor; Cell Survival; Doxorubicin; Drug Resistance, Neoplasm; Humans; NADP; Phosphogluconate Dehydrogenase; Sirtuin 1; Thyroid Carcinoma, Anaplastic | 2018 |